Glucose Health Presents A Unique Investment Opportunity In The Growing Global Diabetes Epidemic

Jul. 19, 2022 4:58 PM ETGlucose Health, Inc. (GLUC)20 Comments
Altitrade Partners profile picture
Altitrade Partners


  • Glucose Health, Inc. is a micro-cap company that is on the leading edge of a long-term global macro trend that likely has a decades-long runway in front of it.
  • This macro trend, which offers a unique investment opportunity, revolves around the increasing number of global cases of Type-2 diabetes, and prediabetes, resulting from several factors including obesity.
  • The challenge is to find a pure play on this growing global epidemic, to leverage the potential return from an equity investment.
  • Glucose Health has a very favorable capital structure, a strong revenue stream, growing at triple-digits, and a CEO with strong incentives to enhance shareholder value. GLUC has no debt.
  • The company’s flagship product, GlucoDown®, has experienced robust sales at Walmart and Amazon, leading to frequent stock outs and depleted inventory levels. Additional capital is needed to alleviate this problem.
Medical background concept

Evgeny Gromov/iStock via Getty Images

Revisiting Former Micro-Cap Idea Glucose Health

We are using this opportunity to revisit our prior bullish investment thesis on Glucose Health, Inc. (OTCPK:GLUC), given that the company has announced the filing of an S-1 registration statement to

This article was written by

Altitrade Partners profile picture
My investment experience includes a Wall Street career spanning over 35 years. I am retired now, and spend my time as a full-time trader and investor. I especially enjoy the research process and am always looking for the next big ten-bagger. My focus is on small caps, undiscovered companies and special situations.

Disclosure: I/we have a beneficial long position in the shares of GLUC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: Additional Disclosure: Disclaimer: We are not responsible for updating this article, or our opinion on any of the stock(s) that are mentioned in our articles. We are not in the business of giving investment advice and ask that readers refrain from asking us for it. Please do your own due diligence before investing. We are not responsible for any actions that you take based on the opinions that we express on Seeking Alpha.

Please remember that this article is a reflection of our current opinion on GLUC. It is based on information that is publicly available at the time we wrote the article. Additional public information may be available but was not brought to our attention at the time we authored the article. We provide sources and links to factual information that we include in our articles but take no responsibility for the accuracy of their content. An investor should consider that new information may become available regarding the company's business activities, financial condition or corporate governance. It is the responsibility of each investor to make sure that they stay abreast of any new developments which may arise, that could have an impact (negative or positive) on their investment.

GLUC may need to raise additional capital in the future, to continue with its strategic business plan. There can be no assurance that they will be successful in obtaining additional financing, on favorable terms, in the future. Investors should take this into consideration when deciding to invest in the equity securities of GLUC. There always remains the possibility that an investor in GLUC, or any micro-cap company, could lose 100% of their investment.

The principals of Altitrade Partners hold a beneficial interest of greater than 10% of the outstanding common shares of GLUC. In addition, we own shares of preferred stock Series B, C, D, & E issued by the company as a part of the normal course of financing activities by the company. We are not considered to be an affiliate or control person of Glucose Health, Inc. and exercise no influence over decisions made by the company, its CEO, or the Board of Directors.

Glucose Health, Inc. (GLUC) is not currently an SEC reporting company, and as such its shareholders are under no legal obligation to file standard SEC ownership documents, as would be the case with a fully-reporting SEC company. We, however, have chosen to voluntarily disclose our ownership position in the securities of GLUC, in the interest of full and fair disclosure.

Altitrade Partners is not an investment advisory service, and is not a registered investment advisor or broker/dealer. Investors should base any buy and sell decisions on their own due diligence and preferably with the advice of their own financial, tax and investment advisors.

The views and opinions expressed in this report are purely those of Altitrade Partners. No views or opinions should be misconstrued as advice as to whether or not to buy or sell any securities. Altitrade Partners does not offer investment advice, or investment services, and is not compensated to provide opinions, write research reports, or to comment on news related to any publicly traded company.

Each investor is responsible for making his or her own investment decisions, with the assistance of a licensed financial advisor, investment advisor or tax professional to determine whether or not an investment is suitable based on their personal financial goals, circumstances and risk-profile. Readers must understand and acknowledge that there is a very high degree of risk involved in buying and selling securities, especially micro-cap stocks, and any investment decision should be based on a thorough analysis of a company, its business, its financial condition and the securities in its capital structure. No investment decision should not be based solely on what is read in a research report, viewed on a web site, or seen on the Internet. The Principals of Altitrade Partners may hold positions in the equity securities of companies or industries discussed here; including, but not limited to common stock, preferred stock, convertible debt, as well as listed put and call options. Any such positions are disclosed to readers, so that they may be aware of any potential conflicts of interest as a result of the author’s position (long or short) in a security which they are writing about. Understand that such disclosure is made at the time that the opinion is posted, and is subject to change. Such changes may include increasing or decreasing the number of shares held, increasing or decreasing the number of options which may be exercised into common stock, along with hedging strategies designed around taking an offsetting position in the same security, or convertible securities, to manage risk.

The information contained in this article may include or incorporate by reference “forward looking statements” including certain information with respect to business results, plans and strategies of publicly-traded companies. For this purpose, any statements incorporated by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting or forgoing the words “should”, “could”, “may” “believe”, “anticipate”, “plan”, “expect”, “project” and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks, uncertainties, and assumptions about each company, economic and market factors in industries in which the companies do business, among other factors. These statements are in no way guarantees of future performance, and actual events, along with results, may differ materially from those expressed or forecasted by the companies due to many factors.

The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company’s actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company’s products, the company’s ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk.

Micro-cap stocks carry additional risks beyond those of higher classes of securities including, but not limited to trading outside of a listed exchange, potential liquidity issues, dealing with penny-stock rules, lack of margin eligibility, a possible absence of transparency regarding BBBO quotes, a limited number of Market Makers willing to provide depth to the order book, potential issues regarding financing activities, inadequate capital to execute on the company’s business plan, going concern caveats, and the potential inability to compete with larger companies due to limited financial and personnel resources. Please invest responsibly. We encourage individuals to only invest what they can afford to lose, up to a maximum of 100% of their investment.

Recommended For You

Comments (20)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.